Znanstveni rad - Izvorni znanstveni rad
Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure
Acta clinica Croatica, 56 (2017), 4; 733-741. https://doi.org/10.20471/acc.2017.56.04.22


Citirajte ovaj rad

Makarović, S., Makarović, Z., Bilić Ćurčić, I., Milas Ahić, J., Mihaljević, I., Franceschi, M. i Jukić, T. (2017). Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure. Acta clinica Croatica, 56. (4), 733-741. doi: 10.20471/acc.2017.56.04.22

Makarović, Sandra, et al. "Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure." Acta clinica Croatica, vol. 56, br. 4, 2017, str. 733-741. https://doi.org/10.20471/acc.2017.56.04.22

Makarović, Sandra, Zorin Makarović, Ines Bilić Ćurčić, Jasminka Milas Ahić, Ivan Mihaljević, Maja Franceschi i Tomislav Jukić. "Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure." Acta clinica Croatica 56, br. 4 (2017): 733-741. https://doi.org/10.20471/acc.2017.56.04.22

Makarović, S., et al. (2017) 'Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure', Acta clinica Croatica, 56(4), str. 733-741. doi: 10.20471/acc.2017.56.04.22

Makarović S, Makarović Z, Bilić Ćurčić I, Milas Ahić J, Mihaljević I, Franceschi M, i sur.. Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure. Acta clinica Croatica [Internet]. 2017. [pristupljeno 05.10.2024.];56(4):733-741. doi: 10.20471/acc.2017.56.04.22

S. Makarović, et al., "Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure", Acta clinica Croatica, vol. 56, br. 4, str. 733-741, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:386712. [Citirano: 05.10.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.